Similarly, our results showed that CSF2RB expression was correlated to CD8 cell infiltration levels in BRCA and its subtypes, and it could be associated with the immune response in the tumor microenvironment and may lead to immune cell activation or recruitment, which makes it a potential target for breast cancer therapy. This evidence concerns the gene CSF2RB and breast carcinoma.